Medication Management Made Sympl

Symplmed Pharmaceuticals is a new kind of pharmaceutical company. Like our peers, we offer life‑saving and innovative medications—ours and our partners. But only Symplmed is revolutionizing the entire drug delivery process through our patented DyrctAxess technology platform by:

Innovative Products for Hypertension

Our initial product focus is hypertension and features Symplmed’s proprietary ACE inhibitor ACEON® (perindopril erbumine) and Prestalia® (perindopril arginine and amlodipine) tablets. We plan to make Prestalia, the first fixed-dose combination of these two medications, available to physicians and patients within the first quarter of 2015 through our hypertension management program, bpCareConnect. Our growing pipeline includes three additional perindopril FDCs being prepared for Phase III programs in the first half of the year.

Physicians

Learn how you can eliminate the hassles of paperwork and improve patient care with bpCareConnect. It’s available for your desktop, tablet or mobile phone and can be set up in minutes.

LEARN MORE

Patients

Are you living with hypertension? Interested in a better, easier and likely less expensive way to receive your medications and manage your treatment? With your physician, enroll in our hypertension management program, bpCareConnect, today!

LEARN MORE

Latest News

January 26, 2015 Symplmed announces FDA approval of Prestalia® for treatment of hypertension

January 7, 2015 Symplmed brings VAYA Pharma products into DyrctAxess Technology®